INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$4.8M

$4,824,507

View Raw Line-Items
Live Feed: 2026-03-11
BEAM M
Beam Therapeutics Inc.
Ciaramella Giuseppe • President
Other
2026-02-24 $595,000
BEAM S
Beam Therapeutics Inc.
Ciaramella Giuseppe • President
10b5-1 SellΔOwn -15.5%
2026-02-24 $1,120,042Large
BEAM M
Beam Therapeutics Inc.
Evans John M. • CEO
Other
2026-01-30 $16,750
BEAM S
Beam Therapeutics Inc.
Evans John M. • CEO
10b5-1 Sell
2026-01-30 $708,946x2
BEAM M
Beam Therapeutics Inc.
Evans John M. • CEO
Other
2026-01-29 $16,750x2
BEAM S
Beam Therapeutics Inc.
Evans John M. • CEO
10b5-1 Sell
2026-01-29 $734,582x2
BEAM S
Beam Therapeutics Inc.
Bellon Christine • Officer • Chief Legal Officer
10b5-1 Sell
2026-01-22 $46,614
BEAM S
Beam Therapeutics Inc.
Cavanagh Bethany J • Officer • SVP, Finance and Treasurer
10b5-1 SellΔOwn -15.1%
2026-01-22 $216,933
BEAM S
Beam Therapeutics Inc.
Cavanagh Bethany J • Officer • SVP, Finance and Treasurer
10b5-1 Sell
2026-01-20 $91,384
BEAM S
Beam Therapeutics Inc.
Bellon Christine • Officer • Chief Legal Officer
10b5-1 Sell
2026-01-15 $644,832x3
BEAM S
Beam Therapeutics Inc.
FMR LLC • 10% Owner
Discretionary SellΔOwn -97.0%
2025-10-27 $12,246
BEAM M
Beam Therapeutics Inc.
Evans John M. • CEO
Other
2025-10-02 $16,750
BEAM S
Beam Therapeutics Inc.
Evans John M. • CEO
10b5-1 Sell
2025-10-02 $615,668
BEAM S
Beam Therapeutics Inc.
Bellon Christine • Officer • Chief Legal Officer
Sell to Cover
2025-10-01 $9,150
BEAM S
Beam Therapeutics Inc.
Cavanagh Bethany J • Officer • SVP, Finance and Treasurer
Sell to Cover
2025-10-01 $11,456
BEAM M
Beam Therapeutics Inc.
Evans John M. • CEO
Other
2025-10-01 $16,750
BEAM S
Beam Therapeutics Inc.
Evans John M. • CEO
10b5-1 Sell
2025-10-01 $612,655